Iomed says merger amount for ReAble has been set

Salt Lake-based Iomed Inc. said that the per-share amount for its merger with ReAble Therapeutics has been set.

Iomed shareholders will receive cash equal to $2.75 per share in exchange for their Iomed common stock if the merger agreement is approved by Iomed shareholders.

Iomed's board has approved the merger agreement. A special shareholder meeting is scheduled for 10 a.m. Aug. 8 at Iomed headquarters.

Iomed is a drug delivery product and technology company. ReAble is a rehabilitation and orthopedic device company.